Literature DB >> 3415148

[Cutaneous localizations of disseminated Histoplasma capsulatum histoplasmosis in a case of acquired immunodeficiency].

A Dallot1, J J Monsuez, B Chanu, D Vittecocq, O Verola, G Badillet, J Rouffy, P Morel, A Puissant.   

Abstract

A widespread maculo-papular cutaneous rash appeared on a HIV-positive young bisexual Cambodian man. He was treated for Mycobacterium tuberculosis and Pneumocystis carinii infections. He had been residing in France for seven years. Histology showed, within the dermis, abundant extracellular and intramacrophagic yeast-like organisms suggestive of histoplasmosis. Cultured specimens produced a growth of colonies after three weeks on Sabouraud 4 p. 100 dextrose agar at 25 degrees C. Numerous macroconidia were found which made the species diagnosis of Histoplasma capsulatum possible. Despite initiation of therapy with amphotericin B the patient died. Cutaneous involvement with or without specific features is uncommon in disseminated histoplasmosis. The specific cutaneous lesions are protean. They rarely are the presenting sign of initial infection. Disseminated histoplasmosis has a poor prognosis in acquired immunodeficiency syndrome: amphotericin B is not curative. Maintenance suppressive therapy with ketoconazole has been recommended following amphotericin B completion, although break-through has been reported.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415148

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  2 in total

1.  Imported African histoplasmosis in an immunocompetent patient 40 years after staying in a disease-endemic area.

Authors:  Clémence Richaud; Marie-Olivia Chandesris; Fanny Lanternier; Hélène Benzaquen-Forner; Dea Garcia-Hermoso; Capucine Picard; Emilie Catherinot; Marie-Elisabeth Bougnoux; Olivier Lortholary
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

Review 2.  Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration.

Authors:  R Manfredi; A Mazzoni; A Nanetti; F Chiodo
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.